Clarithromycin Based and Levofloxacin Based Quadruple Therapy in Helicobacter Pylori Eradicatio

Phase 3

• Conditions: Helicobacter pylori infection.; Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere; B96.81

• Registration Number: IRCT20200929048884N1
• Lead Sponsor: Ghoum University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 October 2020

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Aged between 18-75
Need to Helicobacter pylori eradicate

Exclusion Criteria

Receive previous treatment to eradicate Helicobacter pylori
History of allergies to the drugs used in the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Helicobacter pylori eradication. Timepoint: One month after the end of treatment. Method of measurement: Stool antigen test.